eCORE
- Cancer
- Global Health
Team
Group Leader
Matilde Esther LLeonart Pajarín
Principal Investigator (PI)
Matilde E. LLeonart
Researchers
Yoelsis García-Mayea
PhD Students
Cristina Mir Pérez, ALmudena Sánchez García, Marina Bataller Fernández
Selected Publications
Paciucci R, Carnero A, LLeonart ME.
Editorial: Reciprocal crosstalk between the tumor microenvironment and cancer stem cells.
Front Immunol. 2024 Nov 5;15:1505225.
DOI: 10.3389/fimmu.2024.1505225
IF: 5.7
Albert Pujol , Xavier León , Anna Holgado , Cristina Valero , Katarzyna Kolanczak, Miquel Quer, David Virós
External validation of the GETTEC algorithm for elective neck dissection in patients candidates for salvage total laryngectomy
Oral Oncol
DOI: 10.1016/j.oraloncology.2024.106686
IF: 4
Llansana, A; Viros Porcuna, D; Vasquez, R; Parellada,
A; Valero, C; Holgado, A; Leon, X
PATH classification: a proposal for patients with HNSCC treated with salvage surgery.
European Archives of Oto-Rhino-Laryngology. Springer. 282-2, pp.971-979.
DOI: 10.1007/s00405-024-08961-x
IF: 1.9
Viros Porcuna, D (AC); Pollan Guisasola, CM; Viña Soria, C;
Verges Fort, P; Palau Viarnes, M; Juesas Iglesias, L; De Virgilio, A
Transoral Robotic Parapharyngeal Space Dissection
Head & Neck. Wiley. 46-10, pp.2657-266.
DOI: 10.1002/hed.27902
IF: 2.4
De Virgilio, A; Viros Porcuna, D; Sampieri, C; Constantino, A.
Is the robot an instrument or an indication for transoral surgery?
2024. Oral Oncology. Elsevier. 153, pp.106716.
DOI: 10.1016/j.oraloncology.2024.106716
IF: 4
Selected Projects
“New therapeutic approaches in head and neck cancer”
Principal Investigator: Matilde E. LLeonart
Agency: Ministerio de Salud Carlos III
Funding: 183,920 €
Period: 2021-2025
Novel therapeutic approaches against COVID-19
Principal Investigator: Matilde E. LLeonart
Agency: La Marató TV3
Funding: 161,875 VHIR (297,000 € whole consortium)
Period: 2022-2024 (3y)
New compounds targeting head and neck cancer as Trojan horses against chemoresistant cells
Principal Investigator: Matilde E. LLeonart
Agency: Agaur
Funding: 20,000 €
Period: 2024 (6m)
Patents
“COMPOUNDS FOR USE IN THE TREATMENT OF CANCERS THAT OVEREXPRESS TSPAN1”
Priority Number: EP23383269
Priority Date: 10/12/2024
Applicants: 60% VHIR, 20% URiV, 20% IQAC-CSIC
Selected Dissemination Activities
Visites escolars en el Dia de les nenes, les dones i la ciència
Place: VHIR
Date: 02/11/2024
Brief: Visit of children from High School to visit our laboratory
MORE INFO
EscoLab
Place: VHIR
Date: 04/10/2024
Brief: VIsit of teenagers from High School to our laboratory
MORE INFO
Visit associatted to the Marato TV3 Project
Place: VHIR
Date: 06/04/2024
Brief: Disseminnation video promoted by La Marató TV3 Foundation
MORE INFO
International Day of Head and Neck cancer
Place: HUVH
Date: 01/01/1970
Brief: Organization of a stand at the entrence of the HUVH with disseminnation activites for patients and families
MORE INFO